SEC Comment Letter for MEDICINOVA INC (MNOV) (CIK 0001226616) (MNOV) — Aug 14, 2019

MEDICINOVA INC (MNOV) (CIK 0001226616)
Date: Aug. 14, 2019 · CIK: 0001226616 · Accession: 0000000000-19-012453

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-233201

Date

August 14, 2019

Author

Yuichi Iwaki

Form

UPLOAD

Company

MEDICINOVA INC (MNOV) (CIK 0001226616)

Letter

August 14, 2019 Yuichi Iwaki Chief Executive Officer MediciNova, Inc. 4275 Executive Square, Suite 300 La Jolla, CA 92037 Re:MediciNova, Inc. Registration Statement on Form S-3 Filed August 9, 2019 File No. 333-233201 Dear Dr. Iwaki: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Donald Field at 202-551-3680 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text

August 14, 2019
Yuichi Iwaki
Chief Executive Officer
MediciNova, Inc.
4275 Executive Square, Suite 300
La Jolla, CA 92037
Re:MediciNova, Inc.
Registration Statement on Form S-3
Filed August 9, 2019
File No. 333-233201
Dear Dr. Iwaki:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Donald Field at 202-551-3680 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance

SecProbe.io